DJIA 16,554.83 -8.47 -0.05%
NASDAQ 4,374.29 4.52 0.10%
S&P 500 1,933.27 2.60 0.13%
market minute promo

ImmunoGen (NASDAQ: IMGN)

10.85 0.07 (0.65%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMGN $10.79 0.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.35
Previous Close $10.78
Daily Range $10.35 - $10.91
52-Week Range $10.31 - $20.25
Market Cap $931.1M
P/E Ratio -13.65
Dividend (Yield) $0.00 (0.0%)
Volume 52,234
Average Daily Volume 918,469
Current FY EPS -$0.85

Sector

Healthcare

Industry

Drugs

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website: http://www.immunogen.com/

News & Commentary

Milestone Payments Push ImmunoGen to a Q2 Profit

A number of amortized milestone and licensing payments help push ImmunoGen to a surprise quarterly profit.

Q4 2014 Immunogen Inc Earnings Conference Call (Webcast)

Why ImmunoGen (IMGN) Might Surprise This Earnings Season - Tale of the Tape

Why ImmunoGen (IMGN) Might Surprise This Earnings Season - Tale of the Tape

Will ImmunoGen's Q4 Earnings Disappoint Again?

ImmunoGen (IMGN) Soars: Stock Up 8.8% - Tale of the Tape

Stock To Watch: Immunogen (IMGN) In Perilous Reversal

3 Biotech Stocks Breaking Out With Big Volume

Friday's ETF Movers: XBI, GDXJ

4 Stocks Spiking on Big Volume

Wednesday's Biggest Movers

Shares Of ImmunoGen Down On Morgan Stanley's Bearish Initiation

See More IMGN News...

IMGN's Top Competitors

IMGN $10.85 (0.65%)
Current stock: IMGN
AMGN $126.63 (-0.60%)
Current stock: AMGN
GILD $92.22 (0.73%)
Current stock: GILD
BIIB $336.44 (0.61%)
Current stock: BIIB